Lung Cancer Trial, Recruiting (NCT06477302)

Lung Cancer Trial, Recruiting NCT06477302 Sponsor: Instituto Nacional de Cancerologia de Mexico Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06477302 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with lung cancer (either small cell or non-small cell type)
You are 18 years of age or older
You are willing to take part and able to sign a consent form after understanding what the study involves
You are currently receiving Respiratory Rehabilitation treatment with a one-month check-in and follow-up
You are currently receiving active medical treatment for your cancer
You may be at any stage of your cancer diagnosis
You have a general ability to carry out daily activities at a reasonable level, as measured by a standard health scoring tool (confirm with trial site)

Who may not be able to join:

You have serious hearing or vision problems that would stop you from understanding instructions or completing questionnaires
You have a severe psychiatric condition, such as schizophrenia or a psychotic disorder, or you are currently dependent on any mind-altering substances
You have significant attention or memory difficulties that would prevent you from understanding instructions or completing questionnaires

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06477302

Sponsor: Instituto Nacional de Cancerologia de Mexico

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT06477302

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with lung cancer (either small cell or non-small cell type)
You are 18 years of age or older
You are willing to take part and able to sign a consent form after understanding what the study involves
You are currently receiving Respiratory Rehabilitation treatment with a one-month check-in and follow-up
You are currently receiving active medical treatment for your cancer
You may be at any stage of your cancer diagnosis
You have a general ability to carry out daily activities at a reasonable level, as measured by a standard health scoring tool (confirm with trial site)

Who may not be able to join:

You have serious hearing or vision problems that would stop you from understanding instructions or completing questionnaires
You have a severe psychiatric condition, such as schizophrenia or a psychotic disorder, or you are currently dependent on any mind-altering substances
You have significant attention or memory difficulties that would prevent you from understanding instructions or completing questionnaires

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Instituto Nacional de Cancerologia de Mexico

Registry

ClinicalTrials.gov

Start date

23 June 2023

Est. completion

23 June 2026

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Contruction of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov